W Group releases its first Global Women’s Health Investment Report
W Group has published The Road to the Era of Scale, its first Global Women’s Health Investment Report, tracking where capital in women’s health actually moved across 2024 and 2025.
The headline finding: women’s health companies raised a record $1.55 billion in disclosed equity in 2025, up 41% year on year, drawn from proprietary tracking of over 500 funding stories and 164 equity rounds across 15 categories and 30+ countries.
The report also flags real-time hormone monitoring as an emerging investment sub-sector worth watching for anyone in our community, alongside a brand-new GLP-1 and metabolic health category that didn’t exist a year ago, anchored by SheMed’s $50 million Series A. 85 companies raised equity in 2025 overall, the highest single-year count W Group has recorded.
Beyond the headline number, the report’s central finding is about where that capital landed rather than how much of it there was, along with one structural risk the ecosystem will need to close in 2026 for the momentum to hold. The full report is available now.